Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?

Bladder Cancer · 2015 · PMC4927848 · PMID 27376120

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep = 0.05actually significant

One randomized trial has reported a decrease in the 2-year recurrence rate from 33% to 22% , although this did not reach statistical significance ( p = 0.05) [ 42 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.